Director, Hepatology/Immunology Portfolio and Pipeline Strategy

Responsibilities

• Portfolio Strategy and Lifecycle Management
• Identify trends in current Hepatology/Immunology brand performance, key specialty customers, and competitors to shape business insights that inform current strategies and GPS.
• Lead U.S. portfolio and lifecycle strategy across in-line and pipeline Hepatology/Immunology assets, ensuring alignment with brand strategy, commercial objectives, and medical priorities and informing resource allocation and investment choices.
• Ensure that insights from in-line brands, customer experience, and external experts are consistently integrated into portfolio decisions - including indication prioritization, sequencing, and lifecycle planning for Hepatology/Immunology medicines.
• Pipeline Strategy and Product Development
• Develop and deliver U.S. market analyses and insights for the Hepatology/Immunology pipeline in partnership with the cross-functional New Products team.
• Translate U.S. customer perspectives (HCPs, patients, payers) into clinical trial and health outcome needs to inform clinical development plans and financial valuations for Hepatology/Immunology assets.
• Establish and ensure delivery of U.S.-specific insights and market assumptions for each Hepatology/Immunology medicine from Phase 2 through LOC activation, approximately 18-24 months prior to launch.
• Serve as a single point of accountability, leadership, and voice of the U.S. customer for Hepatology/Immunology assets at early stage-gates.
• For early-stage Hepatology/Immunology assets, lead disease and product strategies for external stakeholders (HCPs, patients, payers).
• Identify therapeutic and asset-related customer insights and effectively communicate needs to R&D project teams to ensure payer needs are considered as part of clinical development plans.
• Deliver asset-level recommendations for Phase 2, 2b, and 3 stage-gate decisions for Hepatology/Immunology assets.
• Develop and maintain a long-range portfolio vision for Hepatology/Immunology, including asset prioritization, resourcing implications, and strategic planning to support future pipeline opportunities.
• Insights, Analytics, and Market Understanding
• Develop and leverage analytic approaches to understand U.S. customer needs in partnership with Insights & Analytics and Forecasting.
• Provide direction and guidance for market research, competitive intelligence, and quantitative/qualitative analyses for market characterization and customer segmentation.
• Ensure adequate expert input and review of key commercial assessments of the future Hepatology/Immunology therapeutic landscape, including deep insights into patients, customers, marketplace, competitors, and business drivers.
• Translate commercial and environmental assessments into forward-looking insights on how patient, marketplace, and customer needs may evolve over time.
• Maintain understanding of current and future market trends for reimbursement to provide continuously improving perspective for market access inputs.
• Governance, Decision Support, and Business Partnership
• Lead asset r

Benefits

Additional Information

The Director, Hepatology/Immunology Portfolio and Pipeline Strategy leads U.S. portfolio and pipeline strategy for Hepatology/Immunology medicines, spanning in-line brands and pipeline assets from Phase 2 through launch. The role develops and delivers U.S. market analyses and insights, translates U.S. customer perspectives into clinical and health outcome needs, and establishes U.S.-specific insights and market assumptions that inform clinical development plans, financial valuations, and investment decisions for Hepatology/Immunology medicines. In addition, the role drives U.S. business growth through a forward-looking portfolio vision - including asset prioritization, resourcing, and long-range strategic planning - while creating and implementing strategies for the existing portfolio in partnership with global counterparts through market-responsive U.S.-specific initiatives. The Director crafts the U.S. insights for Hepatology/Immunology disease states, competitors and specialties, supports U.S. leadership representation at LOC and Global committees, and serves as a single point of accountability and voice of the U.S. customer and commercial interests for Hepatology/Immunology assets at early stage-gates.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at GSK? Share your experience